New Delhi, April 14 -- Impact investment firm Omnivore is considering investments in animal health, bioinformatics, precision fermentation, and another deal in material science, a top official said.

The firm plans to close between four and six deals this year, of which two will be in the life sciences space. "I would love to do a life sciences deal related to animal science. It's a sector ripe for disruption and has great challenges. The sector has strong economics and good margins," said Mark Kahn, managing partner at Omnivore.

The firm is also planning a couple of exits this year from its second fund. Omnivore is currently in talks with some of the founders of its portfolio companies and bankers about creating an exit strategy. "This ...